|
|
|
Size
|
CASP Virtual Critical Appraisal Workshops - Schedule of Events
|
Ruth Brice |
Fri, 26 Feb 2021 13:46:59 +0000 |
257 lines |
Short SPSS COURSES from Imperial College London
|
Krupa Shukla |
Fri, 26 Feb 2021 12:11:29 +0000 |
94 lines |
2 opportunities for PhD studentships
|
[log in to unmask] |
Mon, 22 Feb 2021 16:59:01 +0000 |
205 lines |
Online Short Course: Practical Statistics for Medical Research, (UCL)
|
Omar, Rumana |
Tue, 16 Feb 2021 16:47:52 +0000 |
126 lines |
Join the 1st European Implementation Event | 27-28 May 2021
|
Ziemann, Alexandra |
Fri, 12 Feb 2021 18:15:23 +0000 |
315 lines |
Re: Covid - Out patient
|
Caroline Blaine |
Fri, 12 Feb 2021 17:52:41 +0000 |
232 lines |
Re: Covid - Out patient
|
Barry Diner |
Fri, 12 Feb 2021 11:44:54 -0600 |
138 lines |
Re: Covid - Out patient
|
Dr: EE. |
Fri, 12 Feb 2021 17:41:10 +0000 |
117 lines |
Covid - Out patient
|
Barry Diner |
Fri, 12 Feb 2021 11:32:02 -0600 |
67 lines |
Evidence-Based Health Care 2021 programmes - upcoming deadline reminder
|
University of Oxford CPD Centre |
Thu, 11 Feb 2021 14:51:25 +0000 |
1494 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Kumara Mendis |
Wed, 10 Feb 2021 07:13:45 +0530 |
2224 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Bill Cayley, Jr |
Tue, 9 Feb 2021 22:48:15 +0000 |
2021 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Wouter Havinga |
Tue, 9 Feb 2021 21:08:57 +0000 |
2107 lines |
Re: OFFICIAL: RECOMMENDATIONS PLEASE: Guides to searching skills in languages other than English
|
Frances Gardner |
Tue, 9 Feb 2021 18:23:38 +0000 |
452 lines |
OFFICIAL: RECOMMENDATIONS PLEASE: Guides to searching skills in languages other than English
|
Caroline DeBrun |
Tue, 9 Feb 2021 17:56:12 +0000 |
178 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
McCormack, James |
Tue, 9 Feb 2021 17:40:45 +0000 |
1504 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Benjamin Djulbegovic MD |
Tue, 9 Feb 2021 17:27:29 +0000 |
1772 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Kumara Mendis |
Tue, 9 Feb 2021 19:49:55 +0530 |
1811 lines |
Most read Evidence & Policy articles in 2020, all Open Access
|
Heather Gibson |
Tue, 9 Feb 2021 13:25:41 +0000 |
232 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Su May Liew |
Tue, 9 Feb 2021 09:08:46 +0800 |
1979 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Benjamin Djulbegovic MD |
Tue, 9 Feb 2021 01:05:09 +0000 |
1407 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Kumara Mendis |
Tue, 9 Feb 2021 05:42:24 +0530 |
1065 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Kumara Mendis |
Tue, 9 Feb 2021 05:30:05 +0530 |
1259 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Srihari, Vinod |
Mon, 8 Feb 2021 23:13:31 +0000 |
2101 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
K Hopayian |
Mon, 8 Feb 2021 20:54:07 +0000 |
2299 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
K Hopayian |
Mon, 8 Feb 2021 20:41:02 +0000 |
1187 lines |
A question from medical student.
|
avinash kumar gupta |
Sat, 6 Feb 2021 01:33:01 +0545 |
77 lines |
2021 Virtual Systematic Review Course! Booking now open!
|
Lydia Searchfield |
Thu, 4 Feb 2021 21:50:21 +0000 |
60 lines |
[WHO Call for experts] Guideline Development Group – Management of obesity in children and adolescents
|
Hector Pardo |
Thu, 4 Feb 2021 17:31:16 +0100 |
68 lines |
Call: Environments by Design: Health, Wellbeing and Place
|
Dennis Jackson |
Thu, 4 Feb 2021 15:32:34 +0000 |
122 lines |
Fixed cut-off? Think again
|
Polychronis Kostoulas |
Thu, 4 Feb 2021 07:03:01 +0000 |
133 lines |
Vacancy: 1 Scientific Project Manager, HTA Area of the Fundación Progreso y Salud, Sevilla (Spain)
|
Rejón Parrilla Juan Carlos |
Wed, 3 Feb 2021 16:36:35 +0000 |
214 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Wouter Havinga |
Wed, 3 Feb 2021 12:34:25 +0000 |
1173 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Kumara Mendis |
Wed, 3 Feb 2021 13:42:26 +0530 |
1043 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Lelia Carvalho |
Tue, 2 Feb 2021 17:41:08 -0300 |
978 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
McCormack, James |
Tue, 2 Feb 2021 19:06:12 +0000 |
1295 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Michael Power |
Tue, 2 Feb 2021 19:05:14 +0000 |
1276 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
McCormack, James |
Tue, 2 Feb 2021 18:38:54 +0000 |
1238 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Guylene Theriault |
Tue, 2 Feb 2021 16:51:47 +0000 |
1388 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Benjamin Djulbegovic MD |
Tue, 2 Feb 2021 16:28:14 +0000 |
1395 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Tom Jefferson |
Tue, 2 Feb 2021 17:27:12 +0100 |
1102 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Ambuj Kumar |
Tue, 2 Feb 2021 11:07:53 -0500 |
1064 lines |
Re: Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Tom Jefferson |
Tue, 2 Feb 2021 17:02:30 +0100 |
1043 lines |
Comparative efficacy of currently approved COVID-19 vaccines with publicly available data
|
Ambuj Kumar |
Tue, 2 Feb 2021 10:52:37 -0500 |
1030 lines |
Seeking Canadian parents to join a virtual health research network
|
Michelle Chan |
Mon, 1 Feb 2021 13:12:59 -0700 |
115 lines |